SWOT Analysis for Lifecore Biomedical Inc

30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

MACD Crossover Below Signal Line
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
MACD crossed below signal line previous end of day
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)